CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Cencora, Inc.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$340.00−0.92 (-0.27%)
Close on Oct 19, 2026
- Market cap
- $65.94B
- P/E (TTM)
- 25.2
- Dividend yield
- 0.65%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
96.1%
183M of 191M shares
Institutional holders
1,344
108 new, 179 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
3 buys · 11 sales
Net sold $12.45M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 16,405,771 | 8.50% | 13G (passive) amendment | Dec 31, 2024 |
| Vanguard Capital Management | 14,210,260 | 7.30% | 13G (passive) | Mar 31, 2026 |
| Walgreens Boots Alliance, Inc. | 10,380,000 | 5.40% | 13D (active) amendment | May 27, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of COR | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 18,213,783 | 9.54% | $5.15B | −1,729,854 | 0.08% |
| Vanguard Capital Management LLC | 12,378,943 | 6.49% | $3.50B | +65,484 | 0.07% |
| Vanguard Portfolio Management LLC | 9,611,756 | 5.04% | $2.72B | +21,342 | 0.12% |
| State Street Corp | 9,273,983 | 4.86% | $2.62B | +83,432 | 0.08% |
| T. Rowe Price Investment Management, Inc. | 7,410,910 | 3.88% | $2.10M | +1,116,614 | 1.37% |
| Price T Rowe Associates Inc /Md/ | 7,132,687 | 3.74% | $2.02M | −191,019 | 0.20% |
| JPMorgan Chase & Co | 5,943,657 | 3.11% | $1.67B | +1,058,179 | 0.09% |
| Geode Capital Management, LLC | 5,454,888 | 2.86% | $1.54B | −111,156 | 0.08% |
| Boston Partners | 4,868,782 | 2.55% | $1.38B | +385,965 | 1.23% |
| Wellington Management Group Llp | 4,559,761 | 2.39% | $1.29B | +11,149 | 0.22% |
| FMR LLC | 4,122,371 | 2.16% | $1.17B | −2,563,898 | 0.05% |
| Morgan Stanley | 4,086,271 | 2.14% | $1.16B | −445,641 | 0.06% |
| Bank Of America Corp /De/ | 3,733,921 | 1.96% | $1.06B | −404,467 | 0.07% |
| Norges Bank | 2,473,825 | 1.30% | $700.04M | New | 0.07% |
| Goldman Sachs Group Inc | 2,274,148 | 1.19% | $643.54M | +61,260 | 0.06% |
| Amundi | 2,229,326 | 1.17% | $630.85M | +676,066 | 0.15% |
| Northern Trust Corp | 2,158,939 | 1.13% | $610.94M | −23,736 | 0.07% |
| Invesco Ltd. | 2,021,234 | 1.06% | $571.97M | −1,966,502 | 0.05% |
| Capital Research Global Investors | 1,979,942 | 1.04% | $560.28M | +20,292 | 0.08% |
| Carmignac Gestion | 1,747,363 | 0.92% | $494.46M | +646,112 | 6.42% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1,344 | 183M | 96.1% | 108 / 434 | 618 / 179 | 19M | 18M |
| Q1 2026 | 1,435 | 183M | 95.9% | 136 / 530 | 544 / 146 | 36M | 17M |
| Q4 2025 | 1,470 | 188M | 98.5% | 229 / 499 | 534 / 89 | 24M | 19M |
| Q3 2025 | 1,358 | 184M | 96.3% | 137 / 538 | 453 / 103 | 21M | 16M |
| Q2 2025 | 1,347 | 186M | 97.7% | 172 / 501 | 469 / 97 | 20M | 20M |
| Q1 2025 | 1,291 | 187M | 98.2% | 193 / 439 | 480 / 108 | 17M | 22M |
| Q4 2024 | 1,228 | 195M | 100.0% | 177 / 480 | 392 / 90 | 11M | 15M |
| Q3 2024 | 1,163 | 201M | 100.0% | 131 / 468 | 389 / 88 | 32M | 16M |
| Q2 2024 | 1,133 | 203M | 100.0% | 102 / 450 | 405 / 113 | 12M | 19M |
| Q1 2024 | 1,154 | 210M | 100.0% | 172 / 393 | 423 / 86 | 43M | 11M |
| Q4 2023 | 1,080 | 179M | 93.6% | 190 / 351 | 403 / 72 | 24M | 10M |
| Q3 2023 | 974 | 164M | 86.1% | 101 / 343 | 368 / 119 | 13M | 9M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of COR | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 5,867,758 | 3.07% | $1.66B | 0.07% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 5,041,886 | 2.64% | $1.43B | 0.09% | Jun 30, 2026 |
| T. Rowe Price Capital Appreciation Fund | 4,437,584 | 2.33% | $1.26B | 1.78% | Jun 30, 2026 |
| Vanguard Mid-Cap Index Fund | 4,005,017 | 2.10% | $1.13B | 0.51% | Jun 30, 2026 |
| Vanguard Health Care Fund | 3,033,825 | 1.59% | $944.55M | 2.47% | Jul 31, 2026 |
| iShares Core S&P 500 ETF | 2,676,128 | 1.40% | $757.29M | 0.09% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 2,489,416 | 1.30% | $670.55M | 0.08% | May 31, 2026 |
| Vanguard Value Index Fund | 1,758,393 | 0.92% | $497.59M | 0.20% | Jun 30, 2026 |
| Fidelity Magellan Fund | 1,554,051 | 0.81% | $439.77M | 1.16% | Jun 30, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF | 1,374,447 | 0.72% | $388.94M | 0.96% | Jun 30, 2026 |
| T. Rowe Price Value Fund, Inc. | 1,202,600 | 0.63% | $340.31M | 1.00% | Jun 30, 2026 |
| Vanguard Mid-Cap Value Index Fund | 1,187,155 | 0.62% | $335.94M | 0.90% | Jun 30, 2026 |
| Investment Co of America | 1,146,598 | 0.60% | $324.46M | 0.18% | Jun 30, 2026 |
| iShares Russell Mid-Cap Growth ETF | 1,102,109 | 0.58% | $311.87M | 1.45% | Jun 30, 2026 |
| Vanguard Dividend Appreciation Index Fund | 1,100,813 | 0.58% | $342.73M | 0.26% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Robert P. Mauch | President & CEO, Director | 69,155 | 0.04% | Feb 24, 2026 |
| Steven H. Collis | Executive Chairman, Director | 305,913 | 0.16% | Sep 18, 2025 |
| Lazarus Krikorian | SVP & Chief Accounting Officer | 16,169 | 0.01% | Sep 2, 2026 |
| Elizabeth S. Campbell | Executive Vice President | 19,455 | 0.01% | Aug 25, 2026 |
| Silvana Battaglia | Executive Vice President | 23,624 | 0.01% | Jul 7, 2026 |
| Eva C. Boratto | Chief Financial Officer | 3 | 0.00% | Jun 30, 2026 |
| James F. Cleary | Chief Financial Officer | 160,363 | 0.08% | Mar 13, 2026 |
| Pawan Verma | EVP, Chief Data & Info Officer | 5,148 | 0.00% | Nov 24, 2025 |
| Lon R. Greenberg | Director | 17,128 | 0.01% | Sep 17, 2026 |
| Lauren M. Tyler | Director | 4,456 | 0.00% | Aug 4, 2026 |
| Ellen Cooper | Director | 893 | 0.00% | Aug 4, 2026 |
| Dennis M. Nally | Director | 13,188 | 0.01% | Aug 4, 2026 |
| Dermot Mark Durcan | Director | 31,767 | 0.02% | Jun 22, 2026 |
| Lorence H. Kim | Director | 4,249 | 0.00% | Mar 9, 2026 |
| Lori Ryerkerk | Director | 1,073 | 0.00% | Mar 9, 2026 |
| Redonda Miller | Director | 3,751 | 0.00% | Mar 9, 2026 |
| Werner Baumann | Director | 3,687 | 0.00% | Mar 9, 2026 |
| Frank Clyburn | Director | 1,724 | 0.00% | Mar 9, 2026 |
| Boots Alliance Holdings LLC Walgreens | 10% owner | 16,738,979 | 8.77% | Feb 10, 2025 |
| Walgreens Boots Alliance, Inc. | 10% owner | 26,277,561 | 13.77% | Feb 10, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Lon R. Greenberg Director | Sep 16, 2026 | Sale | −1,280 | $321.30 | $411.26K | 17,128 |
| Lazarus Krikorian SVP & Chief Accounting Officer | Sep 1, 2026 | Sale(10b5-1 plan) | −985 | $325.97 | $321.08K | 16,169 |
| Elizabeth S. Campbell Executive Vice President | Aug 24, 2026 | Sale | −11,300.47 | $324.12 | $3.66M | 19,455 |
| Dennis M. Nally Director | Jul 31, 2026 | Award | +113 | $311.34 | $35.18K | 13,188 |
| Ellen Cooper Director | Jul 31, 2026 | Award | +97 | $311.34 | $30.20K | 893 |
| Lauren M. Tyler Director | Jul 31, 2026 | Award | +97 | $311.34 | $30.20K | 4,456 |
| Elizabeth S. Campbell Executive Vice President | Jun 30, 2026 | Award | +49.89 | $240.53 | $12.00K | 30,756 |
| Silvana Battaglia Executive Vice President | Jun 30, 2026 | Award | +58.2 | $240.53 | $14.00K | 23,624 |
| Lauren M. Tyler Director | Jun 22, 2026 | Buy | +550 | $270.23 | $148.63K | 4,359 |
| Dermot Mark Durcan Director | Jun 18, 2026 | Buy | +4,000 | $274.19 | $1.10M | 31,767 |
| Dermot Mark Durcan Director | May 28, 2026 | Buy | +4,000 | $266.26 | $1.07M | 27,767 |
| Dennis M. Nally Director | May 1, 2026 | Award | +116 | $304.00 | $35.26K | 13,075 |
| Lauren M. Tyler Director | May 1, 2026 | Award | +99 | $304.00 | $30.10K | 3,809 |
| Ellen Cooper Director | May 1, 2026 | Award | +99 | $304.00 | $30.10K | 796 |
| Elizabeth S. Campbell Executive Vice President | Mar 11, 2026 | Tax withholding | −5,842 | $350.30 | $2.05M | 30,706 |
| Elizabeth S. Campbell Executive Vice President | Mar 11, 2026 | Option exercise | +12,623 | – | – | 36,548 |
| Silvana Battaglia Executive Vice President | Mar 11, 2026 | Option exercise | +8,415 | – | – | 27,239 |
| Silvana Battaglia Executive Vice President | Mar 11, 2026 | Tax withholding | −3,673 | $350.30 | $1.29M | 23,566 |
| James F. Cleary Chief Financial Officer | Mar 11, 2026 | Tax withholding | −5,409 | $350.30 | $1.89M | 160,357 |
| James F. Cleary Chief Financial Officer | Mar 11, 2026 | Option exercise | +12,623 | – | – | 165,766 |
| Lauren M. Tyler Director | Mar 5, 2026 | Award | +557 | $359.28 | $200.12K | 3,710 |
| Ellen Cooper Director | Mar 5, 2026 | Award | +557 | $359.28 | $200.12K | 697 |
| Lori Ryerkerk Director | Mar 5, 2026 | Award | +557 | $359.28 | $200.12K | 1,073 |
| Redonda Miller Director | Mar 5, 2026 | Award | +557 | $359.28 | $200.12K | 3,751 |
| Frank Clyburn Director | Mar 5, 2026 | Award | +557 | $359.28 | $200.12K | 1,724 |
| Lon R. Greenberg Director | Mar 5, 2026 | Award | +557 | $359.28 | $200.12K | 18,408 |
| Werner Baumann Director | Mar 5, 2026 | Award | +557 | $359.28 | $200.12K | 3,687 |
| Dermot Mark Durcan Director | Mar 5, 2026 | Award | +905 | $359.28 | $325.15K | 23,767 |
| Dennis M. Nally Director | Mar 5, 2026 | Award | +557 | $359.28 | $200.12K | 12,959 |
| Lorence H. Kim Director | Mar 5, 2026 | Award | +557 | $359.28 | $200.12K | 4,081 |
| Robert P. Mauch President & CEO, Director | Feb 20, 2026 | Option exercise | +3,762 | $86.09 | $323.87K | 69,155 |
| Robert P. Mauch President & CEO, Director | Feb 20, 2026 | Sale(10b5-1 plan) | −3,762 | $358.94 | $1.35M | 65,393 |
| Robert P. Mauch President & CEO, Director | Feb 18, 2026 | Sale(10b5-1 plan) | −1,333 | $359.46 | $479.16K | 65,393 |
| Lauren M. Tyler Director | Jan 30, 2026 | Award | +84 | $359.22 | $30.17K | 3,153 |
| Ellen Cooper Director | Jan 30, 2026 | Award | +69 | $359.22 | $24.79K | 74 |
| Ellen Cooper Director | Jan 30, 2026 | Award | +66 | $359.22 | $23.71K | 140 |
| Dennis M. Nally Director | Jan 30, 2026 | Award | +98 | $359.22 | $35.20K | 12,402 |
| Robert P. Mauch President & CEO, Director | Jan 20, 2026 | Option exercise | +3,763 | $86.09 | $323.96K | 71,822 |
| Robert P. Mauch President & CEO, Director | Jan 20, 2026 | Sale(10b5-1 plan) | −5,096 | $354.73 | $1.81M | 66,726 |
| Elizabeth S. Campbell Executive Vice President | Dec 31, 2025 | Award | +33.53 | $287.09 | $9.63K | 23,925 |
| Silvana Battaglia Executive Vice President | Dec 31, 2025 | Award | +27.34 | $287.09 | $7.85K | 18,824 |
| Silvana Battaglia Executive Vice President | Dec 19, 2025 | Sale | −1,677 | $345.00 | $578.57K | 18,796 |
| Elizabeth S. Campbell Executive Vice President | Dec 19, 2025 | Sale | −3,351 | $342.10 | $1.15M | 23,891 |
| Robert P. Mauch President & CEO, Director | Dec 18, 2025 | Option exercise | +3,763 | $86.09 | $323.96K | 73,155 |
| Robert P. Mauch President & CEO, Director | Dec 18, 2025 | Sale(10b5-1 plan) | −5,096 | $343.45 | $1.75M | 68,059 |
| James F. Cleary Chief Financial Officer | Dec 17, 2025 | Tax withholding | −26,952 | $344.15 | $9.28M | 153,143 |
| James F. Cleary Chief Financial Officer | Dec 17, 2025 | Option exercise | +45,154 | $86.09 | $3.89M | 180,095 |
| Lazarus Krikorian SVP & Chief Accounting Officer | Dec 17, 2025 | Sale | −4,031 | $343.24 | $1.38M | 17,154 |
| Dennis M. Nally Director | Dec 17, 2025 | Gift | −1,173 | – | – | 12,304 |
| Robert P. Mauch President & CEO, Director | Dec 17, 2025 | Gift | −3,000 | – | – | 66,392 |
| Robert P. Mauch President & CEO, Director | Dec 15, 2025 | Option exercise | +638 | – | – | 70,030 |
| Robert P. Mauch President & CEO, Director | Dec 15, 2025 | Tax withholding | −638 | $350.32 | $223.50K | 69,392 |
| James F. Cleary Chief Financial Officer | Dec 15, 2025 | Tax withholding | −199 | $350.32 | $69.71K | 134,941 |
| James F. Cleary Chief Financial Officer | Dec 15, 2025 | Option exercise | +199 | – | – | 135,140 |
| Lazarus Krikorian SVP & Chief Accounting Officer | Dec 15, 2025 | Tax withholding | −91 | $350.32 | $31.88K | 21,185 |
| Lazarus Krikorian SVP & Chief Accounting Officer | Dec 15, 2025 | Option exercise | +91 | – | – | 21,276 |
| James F. Cleary Chief Financial Officer | Nov 20, 2025 | Option exercise | +1,876 | – | – | 135,765 |
| James F. Cleary Chief Financial Officer | Nov 20, 2025 | Tax withholding | −824 | $362.07 | $298.35K | 134,941 |
| Robert P. Mauch President & CEO, Director | Nov 20, 2025 | Option exercise | +5,790 | – | – | 71,536 |
| Robert P. Mauch President & CEO, Director | Nov 20, 2025 | Tax withholding | −2,144 | $362.07 | $776.28K | 69,392 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Greenberg Lon Director | Sep 16, 2026 | 1,280 | $411.28K | Sep 16, 2026 | Director Compensation |
| Silvana Battaglia Former Officer | Sep 11, 2026 | 1,324 | $430.30K | Sep 11, 2026 | Restricted Stock Vesting |
| James F. Cleary Former Officer | Sep 4, 2026 | 10,000 | $3.35M | Sep 4, 2026 | Option Granted |
| Silvana Battaglia Former Officer | Sep 1, 2026 | 6,593 | $2.18M | Sep 1, 2026 | Restricted Stock Vesting |
| Elizabeth S. Campbell Officer | Aug 24, 2026 | 11,301 | $3.66M | Aug 24, 2026 | ESPP Purchase |
| James F. Cleary Officer | Aug 6, 2026 | 20,000 | $6.33M | Aug 6, 2026 | Restricted Stock Vesting |
| Robert P. Mauch Officer, Director | Feb 20, 2026 | 3,762 | $1.35M | Feb 20, 2026 | Option Granted - 11/13/2019 |
| Robert P. Mauch Officer, Director | Feb 18, 2026 | 1,333 | $479.16K | Feb 18, 2026 | Restricted Stock Vesting |
| Robert P. Mauch Officer, Director | Jan 20, 2026 | 5,096 | $1.81M | Jan 20, 2026 | Restricted Stock Vesting |
| Elizabeth S. Campbell Officer | Dec 19, 2025 | 3,351 | $1.15M | Dec 19, 2025 | Restricted Stock Vesting |
| Silvana Battaglia Officer | Dec 19, 2025 | 1,677 | $578.57K | Dec 19, 2025 | Restricted Stock Vesting |
| Robert P. Mauch Officer, Director | Dec 18, 2025 | 5,096 | $1.75M | Dec 18, 2025 | Restricted Stock Vesting |
| Lazarus Krikorian Officer | Dec 17, 2025 | 4,031 | $1.38M | Dec 17, 2025 | Restricted Stock Vesting |
| Robert P. Mauch Officer, Director | Nov 18, 2025 | 5,096 | $1.87M | Nov 18, 2025 | Restricted Stock Vesting |
| Steven H. Collis Former Officer & Director | Nov 18, 2025 | 31,349 | $11.49M | Nov 18, 2025 | Restricted Stock Vesting |